Pharmaceutical economics & health policy -: Editorial comment

被引：0
作者：
Sclar, DA
机构：
来源：
CLINICAL THERAPEUTICS | 1998年 / 20卷 / 01期
关键词：
D O I：
10.1016/S0149-2918(98)80042-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
[41]   Pharmaceutical economics and policy. [J].
Hicks, LL .
INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 1998, 35 (01) :91-91
[42]   Public administration and public policy: Is pharmacoeconomic evidence considered in decisions on pharmaceutical policy? - Editorial comment [J].
Lyles, Alan .
CLINICAL THERAPEUTICS, 2007, 29 (09) :2094-2095
[43]   Use of patient-reported outcomes in pharmaceutical economics and health policy [J].
Barr, Judith .
CLINICAL THERAPEUTICS, 2006, 28 (10) :1710-1711
[44]   Showcasing Pharmaceutical Economics, Outcomes, and Health Policy: An Update in Clinical Therapeutics [J].
Lau, Denys T. .
CLINICAL THERAPEUTICS, 2013, 35 (04) :354-355
[45]   ECONOMICS IN THE POLICY PROCESS - A COMMENT [J].
GOODE, R .
NATIONAL TAX JOURNAL, 1994, 47 (02) :403-405
[46]   EDITORIAL POLICY STATEMENT - COMMENT [J].
ALEIXANDRE, MPJ .
SCIENCE EDUCATION, 1995, 79 (06) :701-704
[47]   Health Economics and Policy [J].
Rawlings, Louise ;
Robson, Steve .
ECONOMIC RECORD, 2019, 95 (308) :173-176
[48]   What does economics have to say about health policy anyway? Comment [J].
Gaynor, M ;
Vogt, WB .
JOURNAL OF HEALTH POLITICS POLICY AND LAW, 1997, 22 (02) :475-496
[49]   Health Economics in the Canadian Pharmaceutical Industry [J].
Lila Assiff ;
Michael R. Pollock ;
Patricia Manzi ;
Ben Faienza ;
Devidas Menon .
PharmacoEconomics, 1999, 16 :669-678
[50]   Health economics in the Canadian pharmaceutical industry [J].
Assiff, L ;
Pollock, MR ;
Manzi, P ;
Faienza, B ;
Menon, D .
PHARMACOECONOMICS, 1999, 16 (06) :669-678
12345